Home/ Supplements/ Omega 3/ Omega 3 500

Omega 3 500

product on market Softgel Capsule Reliable-1 Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Fish oil provides omega-3 fatty acids, which have strong evidence for supporting cardiovascular health and reducing inflammation. Vitamin E acts as an antioxidant to protect the oils from oxidation. Overall, the evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega 3 500
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
1 IU (3% DV)
Market median: 80.0mg (1390 products) 179 studies (A:3, B:90)
1000 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Glycerin purified Water Soybean Oil
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: Adults: Take one (1) softgel daily with a meal.

Warnings & Precautions

Keep out of reach of children

Do not use if imprinted safety seal under cap is broken or missing .

Contains fish (sardine and anchovy)

Formulation Notes

Free of: milk, egg, shellfish, tree nuts, wheat, and peanut.

Contains fish (sardine and anchovy)

Additional Information

Keep bottle tightly closed. Store between 15(0)-30(0)C (59(0)-86(0)F).

Rev. 0915 11753seg 180cc

Metadata

Product Details

UPC / SKU3 69618 00405 4
DSLD Entry Date2018-09-21
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID180299
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.